Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

46.74
+0.60001.30%
Pre-market: 47.150.4090+0.88%05:00 EDT
Volume:10.91M
Turnover:511.14M
Market Cap:206.73B
PE:11.68
High:47.17
Open:46.35
Low:46.34
Close:46.14
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:0.82
T/O Rate:0.34%
Dividend:1.72
Dividend Rate:3.68%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.35
PE(LYR):12.91

Loading ...

Novo Nordisk to seek regulatory approval for Wegovy pill in China soon, says CEO

Reuters
·
Jun 16

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 16

Novo Nordisk A/S Stock Rises Friday, Underperforms Market

Dow Jones
·
Jun 13

Update: Market Chatter: Some US Employers Plan to Drop GLP-1 Coverage for Obesity in 2027

MT Newswires Live
·
Jun 12

Sector Update: Healthcare Stocks Rise Thursday Afternoon

MT Newswires Live
·
Jun 12

Dow Jones Top Company Headlines at 1 PM ET: SpaceX IPO Draws at Least $5 Billion Order From BlackRock | Amazon ...

Dow Jones
·
Jun 12

Novo Nordisk Reports Cybersecurity Incident Involving IT System Access

MT Newswires Live
·
Jun 12

Novo Nordisk's Wegovy Pill Gains U.K. Approval, Its First in Europe -- Update

Dow Jones
·
Jun 12

Novo Nordisk hit by cyber incident, probes data breach

Bloomberg
·
Jun 11

BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle

Reuters
·
Jun 11

Novo Nordisk announces security incident on ‘limited number’ of systems

TIPRANKS
·
Jun 11

Novo Nordisk reports Wegovy pill approved in UK

TIPRANKS
·
Jun 11

Novo Nordisk Has Clear Lead in Oral Weight-Loss Market -- Market Talk

Dow Jones
·
Jun 11

Market Chatter: Employers to Drop Coverage for Weight-loss Drugs

MT Newswires Live
·
Jun 11

Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jun 11

Europe's Big Pharma Could Win Investors' Favor With Busy End of Year -- Market Talk

Dow Jones
·
Jun 10

Movement Alert|Novo Nordisk Rises 3.15% in Regular Trading, ADA Clinical Data and Oral Wegovy Prescriptions Surpassing 3 Million Drive Gains

Market Focus
·
Jun 10

Novo Nordisk faces off in court with South African weight-loss drug compounder

Reuters
·
Jun 10

Assessing Novo Nordisk (NYSE:NVO) Valuation After Recent Share Weakness And GLP‑1 Growth Questions

Simply Wall St.
·
Jun 10

Movement Alert|Novo Nordisk Rises 3.13% in Regular Trading, Oral Wegovy Prescriptions Surpass 3 Million Amid ADA Conference Catalysts

Market Focus
·
Jun 10